Results 11 to 20 of about 2,605,313 (261)
Primary cytoreductive surgery or interval cytoreductive surgery
Yiu-Tai Li, Szu-Ting Yang, Peng-Hui Wang
doaj +4 more sources
Background Cytoreductive surgery followed by systemic chemotherapy is the standard of treatment in advanced ovarian cancer where feasible. Neoadjuvant chemotherapy (NACT) followed by surgery is applicable where upfront cytoreductive surgery is not ...
Ester Miralpeix +6 more
doaj +2 more sources
The efficacy of cytoreductive surgery for oligometastatic prostate cancer: a meta-analysis
Backgrounds At present, the application of tumor reduction surgery in oligometastatic prostate cancer has aroused extensive discussion among urologists, but clinicians have not reached a consensus on this issue.
Bisheng Cheng, Shuchao Ye, Peiming Bai
doaj +2 more sources
The current role of secondary cytoreductive surgery for recurrent ovarian cancer
Ovarian cancer represents worldwide the second most frequent and the most fatal gynecological malignancy, with approximately two thirds of the patients presenting with advanced disease. Cytoreductive surgery, primary or after neoadjuvant chemotherapy, in
Eelco de Bree +2 more
doaj +2 more sources
Impact of postoperative infection on changes in leucocyte levels in early postoperative period in patients undergoing splenectomy during cytoreductive surgery for gynaecological malignancy [PDF]
Background In cytoreductive surgery for gynecological cancers, 13-25% of patients require splenectomy. Therefore, hematological parameters change in the post-splenectomy period, especially leucocytosis and thrombocytosis.
Yeşim Özkaya Uçar +8 more
doaj +2 more sources
PURPOSE In patients with peritoneal metastasis (PM) from gastric cancer (GC), chemotherapy is the treatment of choice. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are still being debated. This randomized, controlled,
B. Rau +27 more
semanticscholar +1 more source
Objectives: This study aimed to compare the short and long-term outcomes of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy and resection of isolated peritoneal metastases in patients with peritoneal metastases from colorectal cancer
Shinya Yoshida +7 more
doaj +1 more source
Key Points Question Does hyperthermic intraperitoneal chemotherapy (HIPEC) after primary or interval cytoreductive surgery increase survival in patients with ovarian cancer?
M. Lim +6 more
semanticscholar +1 more source
Robotic-assisted interval cytoreductive surgery in ovarian cancer: a feasibility study [PDF]
ObjectiveThe primary objective was to assess the feasibility of robotic-assisted interval cytoreductive surgery for achieving complete cytoreduction for patients with advanced-stage ovarian cancer. The secondary objective was to examine the perioperative
Semiramis L. Carbajal-Mamani +6 more
doaj +1 more source
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer.
BACKGROUND Treatment for patients with recurrent ovarian cancer has been mainly based on systemic therapy. The role of secondary cytoreductive surgery is unclear.
P. Harter +29 more
semanticscholar +1 more source

